Ingpuls Medical presents itself at COMPAMED 2022
Ingpuls Medical enjoyed strong interest from the trade audience at COMPAMED 2022. As a new joint venture consisting of Ingpuls and Resonetics, Ingpuls Medical has officially become part of the medical technology industry since the beginning of 2022. The goal of Ingpuls Medical is to significantly improve the material quality of Nitinol for medical technology. Thus enabling medical technology companies to develop higher-quality products for the medical sector.
The starting point for this is the supplied Nitinol cast material and the further processing of this into Nitinol tubes, wires, sheets and powder. With an innovative, holistic approach and the combined, specific expertise of Ingpuls and Resonetics, Ingpuls Medical aroused the interest of the trade audience at COMPAMED.
Ingpuls Medical arouses interest of the trade audience
Ingpuls Medical enjoyed strong interest from the trade audience at COMPAMED 2022. As a new joint venture consisting of Ingpuls and Resonetics, Ingpuls Medical has officially become part of the medical technology industry since the beginning of 2022. The goal of Ingpuls Medical is to significantly improve the material quality of Nitinol for medical technology. Thus enabling medical technology companies to develop higher-quality products for the medical sector. The starting point for this is the supplied Nitinol cast material and the further processing of this into Nitinol tubes, wires, sheets and powder. With an innovative, holistic approach and the combined, specific expertise of Ingpuls and Resonetics, Ingpuls Medical aroused the interest of the trade audience at COMPAMED.
High-quality presentation at COMPAMED 2022
A dedicated team of engineers, technicians and production staff from Ingpuls Medical did the groundwork for Ingpuls Medical’s successful participation at the COMPAMED 2022 trade show. Together with joint venture partner Resonetics, Ingpuls succeeded in developing several material states in record time and caught up with the best on the market in its first year.
Exchange between Ingpuls and Resonetics
The joint venture at COMPAMED 2022 not only aroused the interest of the professional audience in Ingpuls Medical, but also enhanced the interactive communication between the colleagues from Resonetics and Ingpuls. At COMPAMED, Ingpuls Medical was represented by the management as well as by employees from engineering and sales.
